Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
This study has been completed.
First Posted: July 18, 2012
Last Update Posted: November 6, 2015
Information provided by (Responsible Party):